13F GuideFiling Basics
What is SEC Form 13F? Ultimate Guide to Institutional Equity Filings
Learn how SEC Form 13F filings work, the $100M threshold, 45-day reporting lag, and how to track top hedge fund holdings.
AlphaSMO Research GuideRead Guide
CIK: 0001358331
Total reported value
$369.5M
$369.5M
39 檔
34.0%
During the Q3 2025 filing period, Bruce & Co., Inc. (CIK: 0001358331) submitted its Form 13F report to the U.S. SEC, disclosing a tracked public equity portfolio valued at $369.5M across 39 reported positions.
In Q3 2025, Bruce & Co., Inc. adopted a defensive or profit-taking posture, trimming 7 positions and completely liquidating 4 holdings to manage risk exposure.
| # | Ticker | Issuer | Asset Subclass | Weight | Weight Change | Shares Change | 4Q Trend |
|---|---|---|---|---|---|---|---|
| 1 | ABBV | Abbvie Inc | Stock-Healthcare | 9.14% | +0.62% | — | |
| 2 | ALL | Allstate CORP | Stock-Financials | 8.34% | +0.56% | — | |
| 3 | NEE | NextEra Energy, Inc. | Stock-Utilities | 7.36% | -0.99% | — | |
| 4 | UHAL-B | U-haul Holding Co-non Voting | Stock-Other | 7.12% | +0.74% | — | |
| 5 | AER | AerCap Holdings N.V. | Stock-Industrials | 6.88% | +0.10% | — | |
| 6 | DUK | Duke Energy CORP | Stock-Utilities | 5.97% | -0.50% | -11.38% | |
| 7 | ABT | Abbott Laboratories | Stock-Healthcare | 5.55% | -0.58% | — | |
| 8 | MRK | Merck & Co., Inc. | Stock-Healthcare | 5.01% | +0.01% | — | |
| 9 | XEL | Xcel Energy Inc | Stock-Utilities | 4.86% | -0.22% | — | |
| 10 | T | At&t Inc | Stock-Comm Services | 4.57% | -1.44% | -22.29% | |
| 11 | IIIN | Insteel Industries Inc | Stock-Other | 4.08% | -0.52% | — | |
| 12 | CMS | Cms Energy CORP | Stock-Utilities | 3.54% | -0.29% | -20.41% | |
| 13 | AAPL | Apple Inc | Stock-Tech | 3.07% | +0.07% | — | |
| 14 | NEM | Newmont CORP | Stock-Materials | 2.61% | -0.57% | — | |
| 15 | AVA | Avista CORP | Stock-Utilities | 2.36% | -0.10% | — | |
| 16 | PFE | Pfizer Inc | Stock-Healthcare | 2.15% | -0.43% | — | |
| 17 | BG | Bunge Global SA | Stock-Consumer Staples | 2.01% | -0.53% | — | |
| 18 | ADM | Archer-daniels-midland Co | Stock-Consumer Staples | 1.85% | -0.01% | — | |
| 19 | KOD | Kodiak Sciences Inc | Stock-Other | 1.42% | -0.05% | -13.53% | |
| 20 | VICR | Vicor CORP | Stock-Tech | 1.39% | +1.94% | — | |
| 21 | UHAL | U-haul Holding Co | Stock-Other | 1.31% | +0.28% | — | |
| 22 | DAR | Darling Ingredients Inc | Stock-Consumer Staples | 1.25% | -0.33% | — | |
| 23 | CC | Chemours Co/the | Stock-Materials | 1.23% | -0.19% | — | |
| 24 | SUPN | Supernus Pharmaceuticals Inc | Stock-Healthcare | 1.22% | +0.41% | — | |
| 25 | LYB | LyondellBasell Industries N.V. | Stock-Materials | 0.91% | -0.53% | +50.00% | |
| 26 | RLI | Rli CORP | Stock-Financials | 0.82% | -0.03% | — | |
| 27 | PSNL | Personalis Inc | Stock-Other | 0.51% | +0.42% | — | |
| 28 | LLY | Eli Lilly & Co | Stock-Healthcare | 0.47% | +0.12% | — | |
| 29 | VG | Venture Global Inc-cl A | Stock-Energy | 0.44% | -0.15% | — | |
| 30 | SIRIEUR | Sirius Xm Holdings Inc | Stock-Other | 0.40% | +0.08% | — | |
| 31 | VALE | Vale S.A. | Stock-Materials | 0.34% | -0.02% | — | |
| 32 | MNKD | Mannkind CORP | Stock-Other | 0.32% | +0.08% | — | |
| 33 | FOCL | Edap Tms SA -adr | Stock-Other | 0.31% | +0.15% | -20.77% | |
| 34 | FATE | Fate Therapeutics Inc | Stock-Other | 0.28% | +0.45% | +69.90% | |
| 35 | ASH | Ashland Inc. | Stock-Materials | 0.22% | +0.03% | — | |
| 36 | MASS | 908 Devices Inc | Stock-Other | 0.19% | +0.04% | — | |
| 37 | CRBU | Caribou Biosciences Inc | Stock-Other | 0.18% | -0.02% | — | |
| 38 | VTRS | Viatris Inc | Stock-Healthcare | 0.18% | +0.02% | — | |
| 39 | WEC | Wec Energy Group Inc | Stock-Utilities | 0.14% | -0.01% | — |
| # | Ticker | Issuer | Weight Change | Shares Change | Action |
|---|---|---|---|---|---|
| 1 | IIIN | Insteel Industries Inc | +1.2% | — | Unchanged |
| 2 | KOD | Kodiak Sciences Inc | +1.1% | -13.53% | Trim |
| 3 | NEM | Newmont CORP | +1.1% | — | Unchanged |
| 4 | AER | AerCap Holdings N.V. | +0.9% | — | Unchanged |
| 5 | ABBV | Abbvie Inc | +0.6% | — | Unchanged |
| 6 | XEL | Xcel Energy Inc | +0.4% | — | Unchanged |
| 7 | CC | Chemours Co/the | +0.4% | — | Add |
| 8 | SUPN | Supernus Pharmaceuticals Inc | +0.4% | — | Unchanged |
| 9 | VICR | Vicor CORP | +0.3% | — | Add |
| 10 | ADM | Archer-daniels-midland Co | +0.3% | — | Unchanged |
| 11 | AAPL | Apple Inc | +0.3% | — | Unchanged |
| 12 | PSNL | Personalis Inc | +0.2% | — | Unchanged |
| 13 | NEE | NextEra Energy, Inc. | +0.2% | — | Unchanged |
| 14 | FATE | Fate Therapeutics Inc | +0.1% | +69.90% | Add |
| 15 | VG | Venture Global Inc-cl A | +0.1% | — | Unchanged |
| 16 | CRBU | Caribou Biosciences Inc | +0.1% | — | Unchanged |
| 17 | MASS | 908 Devices Inc | +0.1% | — | Unchanged |
| 18 | BG | Bunge Global SA | +0.1% | — | Unchanged |
| 19 | WEC | Wec Energy Group Inc | 0% | — | Unchanged |
| 20 | VTRS | Viatris Inc | 0% | — | Unchanged |
| 21 | ALL | Allstate CORP | 0% | — | Unchanged |
| 22 | MNKD | Mannkind CORP | 0% | — | Unchanged |
| 23 | SIRIEUR | Sirius Xm Holdings Inc | — | — | Unchanged |
| 24 | VALE | Vale S.A. | 0% | — | Unchanged |
| 25 | FOCL | Edap Tms SA -adr | 0% | -20.77% | Trim |
| 26 | LLY | Eli Lilly & Co | -0.1% | — | Unchanged |
| 27 | PFE | Pfizer Inc | -0.1% | — | Unchanged |
| 28 | ASH | Ashland Inc. | -0.1% | — | Unchanged |
| 29 | ABT | Abbott Laboratories | -0.1% | — | Unchanged |
| 30 | DAR | Darling Ingredients Inc | -0.2% | — | Trim |
| 31 | RLI | Rli CORP | -0.2% | — | Unchanged |
| 32 | UHAL | U-haul Holding Co | -0.2% | — | Unchanged |
| 33 | AVA | Avista CORP | -0.4% | — | Unchanged |
| 34 | MRK | Merck & Co., Inc. | -0.8% | — | Trim |
| 35 | DUK | Duke Energy CORP | -0.9% | -11.38% | Trim |
| 36 | UHAL-B | U-haul Holding Co-non Voting | -1.5% | — | Unchanged |
| 37 | T | At&t Inc | -1.5% | -22.29% | Trim |
| 38 | CMS | Cms Energy CORP | -1.9% | -20.41% | Trim |
| 39 | LYB | LyondellBasell Industries N.V. | — | NEW | New buy |
| 40 | AXDX 5 12-15-26Bond | Accelerate Diagnostics | — | EXIT | Sold out |
| 41 | ✓ | Lava Therapeutics NV | — | EXIT | Sold out |
| 42 | OGN | Organon & Co | — | EXIT | Sold out |
| 43 | 1K0 | Igm Biosciences Inc | — | EXIT | Sold out |
According to official SEC Form 13F filings, Bruce & Co., Inc. reported a total U.S. public equity portfolio value of $369.5M across 39 disclosed positions in Q3 2025.
During Q3 2025, Bruce & Co., Inc.'s top holdings by market value included ABBV (9.1%)、ALL (8.3%)、NEE (7.4%). The largest single position, ABBV, represented 9.1% of total portfolio value.
Expert Analysis & Guides for Tracking Wall Street Smart Money Movements
Learn how SEC Form 13F filings work, the $100M threshold, 45-day reporting lag, and how to track top hedge fund holdings.
In terms of portfolio concentration, the top 5 core holdings (including ABBV, ALL, NEE) accounted for 34.0% of total reported equity market value during Q3 2025.
Top New Position Initiated
LYB
市值: $2.9M
Top Position Liquidated / Trimmed
AXDX 5 12-15-26
前期市值: $1.3M
In Q3 2025, Bruce & Co., Inc. made 15 total portfolio adjustments, initiating 1 new buys, adding to 3 positions, trimming 7 holdings, and fully liquidating 4 stocks.
All holding records on this page are fetched directly from the U.S. Securities and Exchange Commission (SEC) EDGAR system (Form 13F-HR). AlphaSMO parses CUSIP identifiers and formats data into Schema.org-compliant datasets.
Understand SEC Form 4 insider disclosures for corporate officers, directors, and 10% owners to track executive transactions.
Understand Rule 144 restricted stock sale notices to spot planned insider liquidations before market sell pressure arrives.
Explore the 5% beneficial ownership threshold, 13D vs 13G filing differences, and recent SEC accelerated deadline rules.
Best practices for analyzing 13F quarterly changes without getting misled by stock splits, options, or market valuation drift.
Learn how AlphaSMO's flagship signal detects high-conviction stocks where 13F hedge funds and corporate insiders buy at the same time.